WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹105 Cr | ₹68 Cr | ₹109 Cr | ₹61 Cr | ₹9.13 Cr |
What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹105 Cr |
| Mar2025 | ₹68 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹9.13 Cr |
How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹105 Cr | 53.89 | |
| Mar2025 | ₹68 Cr | -37.42 | |
| Mar2024 | ₹109 Cr | 78.73 | |
| Mar2023 | ₹61 Cr | 567.74 | |
| Mar2022 | ₹9.13 Cr | - | |
Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,870.8 Cr | -0.7% | -19.8% | -0.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -0.7% |
-19.8% |
-0.5% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses